Patients demand access to investigational therapies June 06, 2016 By Bryant Furlow Expanded access or “compassionate use” programs allow patients to use investigational treatments, medical devices, or tests, before they have received FDA approval. How biomarkers can personalize cancer immunotherapy June 06, 2016 By Bryant Furlow ASCO 2016 presenters share how combination therapies and biomarkers can better identify which tumors are likely to succumb to particular immunotherapies ‘Game changing’ migraine drugs on the horizon June 02, 2016 By Tracey Walker There’s no silver bullet for migraine treatments, but treatments are getting more precise as we learn more about the cause of migraines. Four critical components for successful, value-based pharma contracts May 31, 2016 By Marc O'Connor Despite their proliferation, at-risk pharma contracts are still little more than value-based window dressing. Here are four critical components of contracts that can actually move the value meter in the right direction. New agreement supports value-based pharma contracting May 31, 2016 By Tracey Walker Industry experts are using their proprietary data/analysis to help structure contracts between pharmaceutical companies and plans. Spike in drug shortages raises alarm May 30, 2016 By Karen Appold Drug shortages take a toll, especially on emergency department patients. Will price impede recently approved implant for opioid addicts? May 25, 2016 By Tracey Walker Probuphine implant could be a new option for addicts if obstacles, such as price, don’t get in the way. Three ways to maximize value in cancer treatment May 20, 2016 By Marc O’Connor Advancements in treatment show cancer trending towards a chronic condition. Align your cancer chronic care management team now. Here’s how.
Advancements in treatment show cancer trending towards a chronic condition. Align your cancer chronic care management team now. Here's how. Opinion: Top 4 lessons learned from Asembia 2016 May 12, 2016 By Marc O'Connor Insights from the 2016 edition of the largest gathering in specialty pharmacy. New payer trends for opioids coincide with epidemic May 09, 2016 By Tracey Walker A new study examines payer payment shifts for opioids.